Luoxin Group adhering to the strategic concept of “enterprise development through science and technology” sets a scientific research center in Shanghai Spreading River High Technology Park and organizes a scientific research team made up of domestic and overseas high-end scientific and technological talents, which assumes the development of high-tech projects and cultivation of high-tech talents with the help of various superior resources in Spreading River High Technology Park. It forms a triune scientific research system with the headquarter and strongly promotes the development of new drugs. The company is equipped with national-recognized enterprise technology center, national and local engineering laboratory, national postdoctoral workstation, posts for “Mount Tai scholars -- distinguished pharmaceutical experts”, Shandong enterprise academician workstation, Shandong pharmaceutical engineering and technological research center for freeze-dried powder injection, Shandong pharmaceutical engineering laboratory for freeze-dried powder injection and Shandong pharmaceutical key laboratory for freeze-dried powder injection. Luoxin pharmaceutical postdoctoral mobile workstation, teaching and training bases, practice bases and employment bases for graduates established by Shenyang Pharmaceutical University form a solid national scientific research and technology center, giving new energy to the rapid development of the company. One product technology won the Second Prize of National Scientific and Technological Progress Award.

• · 18 products produced by the company are included into national major scientific and technological special projects of “Major New Medicine Development”
• · 4 products are included into “National New Products Program”
• · 12 products are included into “National Torch Plan”
• · 144 products are included into Shandong Torch Plan, Shandong Scientific and Technological Development Plan, Shandong Technological Innovation Project. Many products won “Science and Technology Progress Award”
• ·200 products won Chinese patent for invention. 20 years of patent protection.
  
  

By far, the company has built three bases for manufacturing and has more than 50 production lines of powder injections, freeze-dried powder injections, solid preparations (containing cephalosporins), sprays, aerosols, prefilled syringes, large volume injections, small volume injections, chemical crude drugs and cephalosporins crude drugs, a dozen of dosage forms and over 300 product launching markets, including 48 national new drugs. The company can annually produce 1 billion powder injections, 500 million freeze-dried powder injections, 400 million bottles (bags) of large volume injections, 500 million small volume injections,7 billion tablets, 2 billion capsules, 300 million granules, 80 million dry suspensions, 300 tons of pellets, 1000 tons of crude drugs, 30 million aerosols, 100 million sprays and 100 million prefilled syringes.